A practical tracking guide for GHRP-2, a ghrelin mimetic often paired with GHRH analogs, with attention to cortisol and prolactin.
At a glance
GHRP-2 (Pralmorelin) is one of the original growth hormone releasing peptides — a synthetic ghrelin mimetic that triggers GH release through the GHS receptor. It predates ipamorelin by about a decade and was studied as a diagnostic agent for GH deficiency in Japan. It is not approved by the FDA or EMA for therapeutic use.
GHRP-2 binds the growth hormone secretagogue receptor (GHS-R, the ghrelin receptor) on the pituitary and triggers a GH pulse. It is more potent on a mg-for-mg basis than ipamorelin but is less selective: it produces small but measurable increases in cortisol and prolactin alongside GH. It also stimulates appetite, though less aggressively than GHRP-6.
When paired with a GHRH analog (CJC-1295 no-DAC, sermorelin, or tesamorelin), the two compounds work synergistically — the GHRH primes the pituitary while the GHRP triggers release.
The cortisol and prolactin tracking is what distinguishes a careful GHRP-2 protocol from a careless one. The increases are typically small and clinically irrelevant at standard doses, but they are non-zero and individual response varies.
The most reported acute effects are increased hunger and improved sleep onset. IGF-1 changes are modest with pulsatile dosing — typically less than what continuous DAC dosing produces. Body composition changes are slow and easily confounded by the appetite increase. People who track food honestly often find the appetite signal partially offsets the metabolic benefit.
For someone who wants the cleanest possible profile, ipamorelin is the conservative choice. For someone tracking carefully and willing to monitor cortisol, GHRP-2 is reasonable.
Peptide IA works well with a multi-daily injection log, a fasting-state flag per injection, daily sliders for hunger and sleep depth, and a bloodwork module that plots cortisol and prolactin alongside IGF-1 over time. The visual of three biomarkers moving (or not) together is what makes the data useful.
GHRP-2 is an older, more potent, less selective GH secretagogue. It has a place if you respect its non-selectivity and track the relevant biomarkers. If you skip the cortisol and prolactin tests, you're flying blind on the parts of the molecule that matter most for safety.
Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.